News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
672,774 Results
Type
Article (55146)
Company Profile (170)
Press Release (617458)
Multimedia
Podcasts (113)
Webinars (17)
Section
Business (184927)
Career Advice (2560)
Deals (33537)
Drug Delivery (123)
Drug Development (79044)
Employer Resources (160)
FDA (17432)
Job Trends (14576)
News (325070)
Policy (34623)
Tag
Academia (2727)
Academic (1)
Accelerated approval (14)
Adcomms (33)
Allergies (104)
Alliances (46939)
ALS (116)
Alzheimer's disease (1582)
Antibody-drug conjugate (ADC) (183)
Approvals (17387)
Artificial intelligence (355)
Autoimmune disease (36)
Automation (18)
Bankruptcy (344)
Best Places to Work (11037)
BIOSECURE Act (22)
Biosimilars (136)
Biotechnology (104)
Bladder cancer (102)
Brain cancer (38)
Breast cancer (388)
Cancer (3057)
Cardiovascular disease (254)
Career advice (2144)
Career pathing (34)
CAR-T (201)
CDC (43)
Cell therapy (539)
Cervical cancer (25)
Clinical research (65279)
Collaboration (1074)
Company closure (3)
Compensation (717)
Complete response letters (38)
COVID-19 (2803)
CRISPR (64)
C-suite (362)
Cystic fibrosis (121)
Data (3149)
Decentralized trials (2)
Denatured (31)
Depression (80)
Diabetes (370)
Diagnostics (6237)
Digital health (24)
Diversity (8)
Diversity, equity & inclusion (43)
Drug discovery (149)
Drug pricing (151)
Drug shortages (34)
Duchenne muscular dystrophy (157)
Earnings (72821)
Editorial (50)
Employer branding (20)
Employer resources (145)
Events (100160)
Executive appointments (879)
FDA (19274)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (947)
Gene editing (139)
Generative AI (29)
Gene therapy (434)
GLP-1 (915)
Government (4701)
Grass and pollen (7)
Guidances (219)
Healthcare (18798)
HIV (43)
Huntington's disease (31)
IgA nephropathy (44)
Immunology and inflammation (191)
Immuno-oncology (13)
Indications (42)
Infectious disease (3000)
Inflammatory bowel disease (152)
Inflation Reduction Act (11)
Influenza (71)
Intellectual property (125)
Interviews (462)
IPO (15856)
IRA (54)
Job creations (3915)
Job search strategy (1789)
Kidney cancer (14)
Labor market (50)
Layoffs (581)
Leadership (27)
Legal (8252)
Liver cancer (84)
Longevity (11)
Lung cancer (438)
Lymphoma (219)
Machine learning (12)
Management (56)
Manufacturing (438)
MASH (102)
Medical device (14296)
Medtech (14300)
Mergers & acquisitions (18434)
Metabolic disorders (953)
Multiple sclerosis (100)
NASH (23)
Neurodegenerative disease (152)
Neuropsychiatric disorders (45)
Neuroscience (2332)
NextGen: Class of 2025 (6346)
Non-profit (4277)
Now hiring (40)
Obesity (492)
Opinion (258)
Ovarian cancer (99)
Pain (125)
Pancreatic cancer (126)
Parkinson's disease (196)
Partnered (20)
Patents (331)
Patient recruitment (185)
Peanut (50)
People (56078)
Pharmaceutical (44)
Pharmacy benefit managers (25)
Phase I (19824)
Phase II (28457)
Phase III (22150)
Pipeline (1754)
Policy (246)
Postmarket research (2818)
Preclinical (8172)
Press Release (56)
Prostate cancer (154)
Psychedelics (44)
Radiopharmaceuticals (255)
Rare diseases (531)
Real estate (5719)
Recruiting (64)
Regulatory (24527)
Reports (37)
Research institute (2454)
Resumes & cover letters (423)
Rett syndrome (10)
RNA editing (10)
RSV (61)
Schizophrenia (103)
Series A (165)
Series B (111)
Service/supplier (13)
Sickle cell disease (66)
Special edition (20)
Spinal muscular atrophy (153)
Sponsored (36)
Startups (3529)
State (1)
Stomach cancer (17)
Supply chain (81)
Tariffs (71)
The Weekly (81)
Vaccines (912)
Venture capital (60)
Weight loss (330)
Women's health (43)
Worklife (20)
Date
Last 7 days (524)
Last 30 days (1710)
Last 365 days (31148)
2025 (18226)
2024 (34982)
2023 (39354)
2022 (50538)
2021 (54826)
2020 (53094)
2019 (45210)
2018 (34291)
2017 (32661)
2016 (31651)
2015 (35718)
2014 (28727)
2013 (23984)
2012 (25984)
2011 (26532)
2010 (25011)
Location
Africa (823)
Alabama (66)
Alaska (6)
Arizona (223)
Arkansas (13)
Asia (40903)
Australia (6773)
California (7482)
Canada (2221)
China (709)
Colorado (312)
Connecticut (347)
Delaware (195)
Europe (93276)
Florida (1157)
Georgia (258)
Hawaii (3)
Idaho (57)
Illinois (675)
India (29)
Indiana (341)
Iowa (18)
Japan (241)
Kansas (104)
Kentucky (29)
Louisiana (14)
Maine (68)
Maryland (1055)
Massachusetts (5638)
Michigan (232)
Minnesota (442)
Mississippi (4)
Missouri (97)
Montana (25)
Nebraska (23)
Nevada (83)
New Hampshire (69)
New Jersey (2145)
New Mexico (20)
New York (2077)
North Carolina (1117)
North Dakota (9)
Northern California (3327)
Ohio (232)
Oklahoma (14)
Oregon (35)
Pennsylvania (1607)
Puerto Rico (12)
Rhode Island (38)
South America (1213)
South Carolina (35)
South Dakota (1)
Southern California (2835)
Tennessee (127)
Texas (1131)
United States (27903)
Utah (212)
Virginia (193)
Washington D.C. (74)
Washington State (633)
West Virginia (4)
Wisconsin (78)
672,774 Results for "medical microinstruments s r l".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Maryland’s Life Sciences Scene Boasts Strong R&D, Manufacturing Talent
The Washington, D.C.–Baltimore area ranks in the top six for life sciences R&D and manufacturing talent, according to a CBRE report. The Maryland Department of Commerce’s director of life sciences discusses the workforce and how the state is adapting to changing needs.
July 24, 2025
·
4 min read
·
Angela Gabriel
Press Releases
Merit Medical Acquires Biolife Delaware, L.L.C.
May 20, 2025
·
15 min read
Press Releases
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
May 23, 2025
·
8 min read
Earnings
BioNTech’s Ambitious PD-L1/VEGF Plans Currently Rely on Chinese Manufacturing
BNT327, a PD-L1/VEGF therapy, is still currently being manufactured in China, but BioNTech is working to establish a diversified supply chain, executives said during the company’s Q1 investor call.
May 5, 2025
·
3 min read
·
Tristan Manalac
Earnings
Moderna’s Bancel Nay on M&A, Yay on R&D Partnerships
It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough programs on its hands.
August 1, 2025
·
4 min read
·
Annalee Armstrong
Deals
Frontage Laboratories Acquires Accelera S.r.l.'s Bioanalytical and DMPK Businesses
Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera).
January 2, 2024
·
5 min read
Press Releases
FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients
June 18, 2025
·
5 min read
Press Releases
BRENIG THERAPEUTICS ANNOUNCES APPOINTMENTS OF DAVID L. LUCCHINO AS CEO AND TIEN DAM, M.D., AS CHIEF MEDICAL OFFICER, EXPANDS PIPELINE
July 11, 2025
·
4 min read
Press Releases
Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025
June 2, 2025
·
8 min read
IN PARTNERSHIP WITH PATSNAP
Webinar: Beyond Theory: Real-World AI Wins in Life Science R&D, Faster & Smarter
Are long R&D cycles, overwhelming literature reviews, or patent bottlenecks slowing your path to innovation? In the fast-evolving life science landscape, AI is no longer a luxury, it’s a necessity.
June 25, 2025
·
1 min read
·
BioSpace Insights
1 of 67,278
Next
